Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)

NCT04520711 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Malignant Epithelial Neoplasms

Interventions

BIOLOGICAL: TCR-transduced T cells
DRUG: CDX-1140
DRUG: Pembrolizumab

Sponsor

Providence Health & Services